Advances in Hematology

Advances in Hematology / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 4120631 | 2 pages | https://doi.org/10.1155/2019/4120631

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”

Received24 Jun 2019
Accepted27 Jun 2019
Published16 Jul 2019

The article titled “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update” [1] was found to contain material from previously published work. The articles are as follows:

(i) Freifeld, A. G., E. J. Bow, K. A. Sepkowitz, M. J. Boeckh, J. I. Ito, C. A. Mullen, I. I. Raad, K. V. Rolston, J.-A. H. Young, and J. R. Wingard. “Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America”, Clinical Infectious Diseases, 2011. https://doi.org/10.1093/cid/cir073. [2] (Cited as reference )

(ii) J. Gea-Banacloche, “Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies,” Hematology/the Education Program of the American Society of Hematology, vol. 2013, no. 1, pp. 414–422, 2013. [3] (Cited as reference )

(iii) Amar Safdar, “Principles and Practice of Cancer Infectious Diseases,” 2011. https://doi.org/10.1007/978-1-60761-644-3. [4] (Not cited)

(iv) Aarti S. Bhardwaj & Shyamala C. Navada (2013) Management of Chemotherapy-Induced Neutropenic Fever, Hospital Practice, 41:1, 96-108, DOI: 10.3810/hp.2013.02.1015. [5] (Not cited)

(v) L. Pagano, M. Caira, A. Nosari et al., “The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart project,” Haematologica, vol. 96, no. 9, pp. 1366–1370, 2011. Doi:10.3324/haematol.2011.042598. [6] (Cited as reference )

The article [1] includes an overlap of 437 words with Freifeld, A. G. et al. [2], 405 words with J. Gea-Banacloche et al. [3], 342 words with Amar Safdar et al. [4], 252 words with Aarti S. Bhardwaj et al. [5], and 221 words with L. Pagano et al. [6].

The authors said they did not intend to copy the work of others, but this occurred because some phrases are difficult to rephrase and no new knowledge was presented in this article. The authors apologized for this matter.

References

  1. P. Villafuerte-Gutierrez, L. Villalon, J. E. Losa, and C. Henriquez-Camacho, “Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: A critical review and update,” Advances in Hematology, vol. 2014, Article ID 986938, 9 pages, 2014. View at: Publisher Site | Google Scholar
  2. A. G. Freifeld, E. J. Bow, K. A. Sepkowitz et al., “Executive summary: clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 52, no. 4, pp. 427–431, 2011. View at: Publisher Site | Google Scholar
  3. J. Gea-Banacloche, “Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies,” Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, vol. 2013, pp. 414–422, 2013. View at: Google Scholar
  4. A. Safdar, Principles and Practice of Cancer Infectious Diseases, 2011. View at: Publisher Site
  5. A. S. Bhardwaj and S. C. Navada, “Management of chemotherapy-induced neutropenic fever,” Hospital Practice, vol. 41, no. 1, pp. 96–108, 2015. View at: Publisher Site | Google Scholar
  6. L. Pagano, M. Caira, A. Nosari et al., “The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart project,” Haematologica, vol. 96, no. 9, pp. 1366–1370, 2011. View at: Publisher Site | Google Scholar

Copyright © 2019 Paola Villafuerte-Gutierrez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

647 Views | 446 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.